In June the United States Preventive Services Task Force (USPSTF) issued their report on testing for HCV and they graded testing at-risk populations and a one-time test for everyone born between 1945 and 1965 (Baby Boomers). The grade of ‘B’ for both means that the tests for HCV will be covered under the Affordable Care Act. Maybe now that more people will be tested we will finally find out the true prevalence of HCV in the United States.
This and many more important news stories in June. To stay up to-date on the news and the drugs in development check out our Blog.
Listed below are the latest and greatest postings to our websites.
1. HCV Advocate Newsletter: July, 2013
In This Issue:
- EASL 2013: DAAs Look Good, but Challenges Remain—Part 2 by Liz Highleyman. Liz continues her review of the data from EASL with an emphasis on the interferon add-on therapies some of which are likely to be the next standard of care for HCV treatment.
- Snapshots by
Lucinda K. Porter, RN. Snapshots is back! In this month's review Lucinda discusses the impact of the failed War on Drugs, knowledge of HCV and HIV/HCV coinfection, and the on-going quest to establish a true number of the HCV prevalence in the United States.
- HEALTHWISE: Technically Speaking: Apps and Hepatitis C by
Lucinda K. Porter, RN. The title says it all!
- Myths about Weight Loss
Alan Franciscus, Editor-in-Chief. Who doesn't know that a healthy weight is good for the liver; but there are a lot of myths about weight loss. Myths are dangerous and these myth busters will help. The truth is out there!
2. HBV Journal Review by Christine Kukka —In this month's column Chris reviews the following studies that will help you understand the complexities of hepatitis B:
Experts Describe When to Treat Pregnant Women with Antivirals
Half of Patients Treated Long-Term with Tenofovir Lose HBeAg
Even Patients with High Viral Load Lose HBeAg with Tenofovir
New Type of Interferon Effective in Phase 2 Hepatitis B Trial
Majority of Hepatitis B Patients Have Vitamin D Deficiency
Patients with Healthy Vitamin D Levels Are More Likely to Clear HBsAg
Activists Develop a National Plan to Eradicate Hepatitis B in the U.S.
New Guidelines Urge Britain's Doctors to Improve Hepatitis B Care
Measuring HBsAg Levels May Identify Fibrosis and Avoid Liver Biopsies
HBsAg Levels May Also Predict Cancer Risk in HBeAg-negative Patients
3. Factsheets & Guides: New & Updated!
Be sure to check out our recently updated fact sheets and guides: Drug-Drug interactions (DDIs) are becoming even more important with the new direct acting antivirals. But the interactions are not confined to HCV treatment. Read our Easy C on DDIs.
What Are Drug Interactions?
4. Clinical Trials Postings: Updated—June 17!
Be sure to check out the latest clinical trial postings at the HCV Advocate News & Pipeline Blog. Just click on the links to the Drug Companies at the top and to see which drugs are in trials right now, where the trials are, and how to register for one.
Don’t forget that there is help as close as a phone call – the 877-HELP-4-HEP line (877-435-7443) is available 9:00am to 7:00pm Eastern Time. For more information about the services they offer either call or visit their Website at www.help4hep.org The helpline is run by The Support Partnership: a group of non-profits working together to help people affected by hepatitis C.
5. Top News (Blog) from the HCV Advocate News & Pipeline Blog includes:
and much, much more…..
Executive Director, Hepatitis C Support Project
Editor-in-Chief, HCV Advocate www.hcvadvocate.org
Editor-in-Chief, HBV Advocate www.hbvadvocate.org
**Questions and Comments: Questions and/or comments can be directed to email@example.com
**To receive the eblast in your email inbox simply send an e-mail to: firstname.lastname@example.org with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case.